Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy
Jochen Springer, Anika Tschirner, Kai Hartman, et al.
International Journal of Cardiology (2013) Vol. 168, Iss. 4, pp. 3527-3531
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Uric Acid Promotes Left Ventricular Diastolic Dysfunction in Mice Fed a Western Diet
Guanghong Jia, Javad Habibi, Benjamín C. Bostick, et al.
Hypertension (2014) Vol. 65, Iss. 3, pp. 531-539
Open Access | Times Cited: 132
Cardiac cachexia: hic et nunc
Goran Loncar, Jochen Springer, Markus S. Anker, et al.
Journal of Cachexia Sarcopenia and Muscle (2016) Vol. 7, Iss. 3, pp. 246-260
Open Access | Times Cited: 119
Cardiotoxicity: Cisplatin and long-term cancer survivors
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 175, Iss. 1, pp. 201-202
Closed Access | Times Cited: 99
Oral Drugs Related with Muscle Wasting and Sarcopenia. A Review
Lluís Campins, M. Valero Camps, Ariadna Riera, et al.
Pharmacology (2016) Vol. 99, Iss. 1-2, pp. 1-8
Open Access | Times Cited: 90
Cancer-induced cardiac cachexia: Pathogenesis and impact of physical activity
Yassine Belloum, Françoise Rannou‐Bekono, F. Favier
Oncology Reports (2017) Vol. 37, Iss. 5, pp. 2543-2552
Open Access | Times Cited: 81
Uric acid and xanthine oxidase in heart failure — Emerging data and therapeutic implications
Wolfram Doehner, Ewa A. Jankowska, Jochen Springer, et al.
International Journal of Cardiology (2015) Vol. 213, pp. 15-19
Closed Access | Times Cited: 76
Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist
Seyyed Mohammad Reza Kazemi‐Bajestani, Harald Becher, Konrad Fassbender, et al.
Journal of Cachexia Sarcopenia and Muscle (2014) Vol. 5, Iss. 2, pp. 95-104
Open Access | Times Cited: 69
Cardiotoxicity: Anthracyclines and long term cancer survivors
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 176, Iss. 3, pp. 1326-1328
Closed Access | Times Cited: 50
Formoterol in the treatment of experimental cancer cachexia: effects on heart function
Míriam Toledo, Jochen Springer, Sı́lvia Busquets, et al.
Journal of Cachexia Sarcopenia and Muscle (2014) Vol. 5, Iss. 4, pp. 315-320
Open Access | Times Cited: 49
HERG-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 176, Iss. 3, pp. 1082-1085
Closed Access | Times Cited: 44
The Redox Balance: A Target for Interventions Against Muscle Wasting in Cancer Cachexia?
Fabio Penna, Riccardo Ballarò, Paola Costelli
Antioxidants and Redox Signaling (2020) Vol. 33, Iss. 8, pp. 542-558
Open Access | Times Cited: 33
A challenge in cardiology: The oncosurgery
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 174, Iss. 2, pp. 411-412
Closed Access | Times Cited: 41
M3 muscarinic acetylcholine receptor in cardiology and oncology
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 177, Iss. 2, pp. 646-649
Closed Access | Times Cited: 38
ERBB1/EGFR and ERBB2 (HER2/neu) — Targeted therapies in cancer and cardiovascular system with cardiovascular drugs
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 176, Iss. 3, pp. 1301-1303
Closed Access | Times Cited: 35
Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition
Gaurav Joshi, Manisha Sharma, Sourav Kalra, et al.
Bioorganic Chemistry (2021) Vol. 107, pp. 104620-104620
Closed Access | Times Cited: 27
Cancer multidrug resistance-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 176, Iss. 3, pp. 1306-1308
Closed Access | Times Cited: 34
Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study
Arrigo F.G. Cicero, Martina Rosticci, Angelo Parini, et al.
Internal and Emergency Medicine (2013) Vol. 9, Iss. 6, pp. 655-660
Closed Access | Times Cited: 32
Cardiotoxicity: Trastuzumab and cancer survivors
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 177, Iss. 2, pp. 554-556
Closed Access | Times Cited: 32
Exercise Training as Therapy for Cancer-Induced Cardiac Cachexia
J.M.M. Antunes, Rita Ferreira, Daniel Moreira‐Gonçalves
Trends in Molecular Medicine (2018) Vol. 24, Iss. 8, pp. 709-727
Closed Access | Times Cited: 31
Cardioinhibitory vasovagal syncope in a cancer patient
Pietro Pugliatti, Rocco Donato, Concetta Zito, et al.
International Journal of Cardiology (2014) Vol. 174, Iss. 2, pp. e64-e65
Closed Access | Times Cited: 30
The Janus‐Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established Concepts
Mohamad Assi, Amélie Rebillard
Oxidative Medicine and Cellular Longevity (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 28
Cardiac Cachexia: Unaddressed Aspect in Cancer Patients
Sarama Saha, Praveen Kumar Singh, Partha Roy, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 990-990
Open Access | Times Cited: 15
Febuxostat improves outcome in a rat model of cancer cachexia
Masaaki Konishi, Loes Pelgrim, Anika Tschirner, et al.
Journal of Cachexia Sarcopenia and Muscle (2015) Vol. 6, Iss. 2, pp. 174-180
Open Access | Times Cited: 27
Review of Mechanisms and Treatment of Cancer-Induced Cardiac Cachexia
Vignesh Vudatha, Teja Devarakonda, Christopher Liu, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 1040-1040
Open Access | Times Cited: 13
Cardiac cachexia: hic et nunc
Goran Loncar, Jochen Springer, Markus S. Anker, et al.
International Journal of Cardiology (2015) Vol. 201, pp. e1-e12
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top